Sarah Sloan

1.3k total citations
21 papers, 843 citations indexed

About

Sarah Sloan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sarah Sloan has authored 21 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sarah Sloan's work include Acute Myocardial Infarction Research (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Sarah Sloan is often cited by papers focused on Acute Myocardial Infarction Research (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Sarah Sloan collaborates with scholars based in United States, Norway and United Kingdom. Sarah Sloan's co-authors include Marc S. Sabatine, David A. Morrow, Christopher P. Cannon, Sabina A. Murphy, Eugene Braunwald, Scott D. Solomon, Sripal Bangalore, Jie Qin, Marc A. Pfeffer and Petr Jarolı́m and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Sarah Sloan

19 papers receiving 817 citations

Peers

Countries citing papers authored by Sarah Sloan

Since Specialization

Citations

This map shows the geographic impact of Sarah Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Sloan more than expected).

Fields of papers citing papers by Sarah Sloan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Sloan. The network helps show where Sarah Sloan may publish in the future.

Co-authorship network of co-authors of Sarah Sloan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Sloan. A scholar is included among the top collaborators of Sarah Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Sloan. Sarah Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Potential Of Accelerometry-Derived Gait Features For Assessing The Risk Of Falls In Older Adults 2022 ·Archives of Physical Medicine and Rehabilitation ·Rakesh Pilkar, Sarah Sloan, (unknown), (unknown), Christine C. Guo	0
2	Arginine-vasopressin infusion in a child with cranial diabetes insipidus during hyperhydration therapy with chemotherapy: a therapeutic challenge 2021 ·Endocrinology Diabetes and Metabolism Case Reports ·(unknown), Sarah Sloan, (unknown), Paul Dimitri	1
3	Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease 2014 ·Journal of the American College of Cardiology ·Jacob A. Udell, David A. Morrow, Petr Jarolı́m, Sarah Sloan, Elaine Hoffman, Thomas F.X. O’Donnell, Amit N. Vora, Torbjørn Omland, Scott D. Solomon, Marc A. Pfeffer, Eugene Braunwald, Marc S. Sabatine	78
4	Clinical Implications and Correlates of Q Waves in Patients With ST‐Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY‐TIMI 28 Trial 2014 ·Clinical Cardiology ·Jonathan W. Waks, Marc S. Sabatine, Christopher P. Cannon, David A. Morrow, C. Michael Gibson, Stephen D. Wiviott, Robert P. Giugliano, Sarah Sloan, Benjamin M. Scirica	3
5	Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease 2013 ·Journal of the American College of Cardiology ·Michelle L. O’Donoghue, David A. Morrow, Sotirios Tsimikas, Sarah Sloan, (unknown), Elaine Hoffman, Nihar R. Desai, Scott D. Solomon, Michaël Domanski, Kiyohito Arai, Stephanie E. Chiuve, Christopher P. Cannon, Frank M. Sacks, Marc S. Sabatine	155
6	Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition 2013 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Owen Mogabgab, Stephen D. Wiviott, Christopher P. Cannon, Sarah Sloan, Marc S. Sabatine, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano	13
7	Dynamic TIMI Risk Score for STEMI 2013 ·Journal of the American Heart Association ·(unknown), David A. Morrow, Eugene Braunwald, Sarah Sloan, Charles F. Contant, Sabina A. Murphy, Elliott M. Antman	46
8	ASSOCIATION OF FIBROBLAST GROWTH FACTOR (FGF)-23 LEVELS WITH RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE 2012 ·Journal of the American College of Cardiology ·Jacob A. Udell, (unknown), David A. Morrow, Petr Jarolı́m, Torbjørn Omland, Sarah Sloan, Marc A. Pfeffer, Eugene Braunwald, Marc S. Sabatine	10
9	Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease 2011 ·Circulation ·Marc S. Sabatine, David A. Morrow, James A. de Lemos, Torbjørn Omland, Sarah Sloan, Petr Jarolı́m, Scott D. Solomon, Marc A. Pfeffer, Eugene Braunwald	108
10	Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome 2011 ·European Heart Journal ·Babak Nazer, Kausik K. Ray, Sarah Sloan, (unknown), David A. Morrow, Christopher P. Cannon, Eugene Braunwald	25
11	Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients with Stable Coronary Disease 2011 ·Circulation ·Marc S. Sabatine, David A. Morrow, James A. de Lemos, Torbjørn Omland, Sarah Sloan, Petr Jarolı́m, Scott D. Solomon, Marc A. Pfeffer, Eugene Braunwald	0
12	What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes? 2010 ·Circulation ·Sripal Bangalore, Jie Qin, Sarah Sloan, Sabina A. Murphy, Christopher P. Cannon, (unknown)	155
13	Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease 2010 ·Circulation ·Jessica L. Mega, Judith S. Hochman, Benjamin M. Scirica, Sabina A. Murphy, Sarah Sloan, Carolyn H. McCabe, Piera Angelica Merlini, David A. Morrow	46
14	Abstract 1131: The Prognostic Utility of Secretory Phospholipase A2 in Patients With Stable Coronary Artery Disease 2009 ·Circulation ·Michelle L. O’Donoghue, Ziad Mallat, David A. Morrow, Joëlle Bénessiano, Sarah Sloan, Alain Tedgui, Marc S. Sabatine	1
15	Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction 2009 ·American Heart Journal ·James Harkness, Marc S. Sabatine, Eugene Braunwald, David A. Morrow, Sarah Sloan, Stephen D. Wiviott, Robert P. Giugliano, Elliott M. Antman, Christopher P. Cannon, Benjamin M. Scirica	7
16	Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: Observations from the PROTECT-TIMI 30 Trial 2009 ·American Heart Journal ·Sean R. Wilson, Marc S. Sabatine, Eugene Braunwald, Sarah Sloan, Sabina A. Murphy, David A. Morrow	63
17	Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome 2009 ·Journal of the American College of Cardiology ·C. Michael Gibson, Yuri B. Pride, (unknown), Sarah Sloan, Marc S. Sabatine, Christopher P. Cannon	82
18	Relation Between Myocardial Infarct Size and Ventricular Tachyarrhythmia Among Patients With Preserved Left Ventricular Ejection Fraction Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction 2009 ·The American Journal of Cardiology ·Yuri B. Pride, Evan Appelbaum, (unknown), Sarah Sloan, Christopher P. Cannon, Marc S. Sabatine, C. Michael Gibson	17
19	Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction 2009 ·Circulation ·Susan Cheng, David A. Morrow, Sarah Sloan, Elliott M. Antman, Marc S. Sabatine	26
20	Self-resolving spontaneous spinal epidural hæmatoma in a patient on anti-coagulant therapy: a case study 2000 ·Sarah Sloan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact